Role of biomarkers in the management of antibiotic therapy : an expert panel review : I - currently available biomarkers for clinical use in acute infections
In the context of worldwide increasing antimicrobial resistance, good antimicrobial prescribing in more needed than ever; unfortunately, information available to clinicians often are insufficient to rely on. Biomarkers might provide help for decision-making and improve antibiotic management. The pur...
Saved in:
Published in | Annals of intensive care 1 (3), 1-8. (2013) |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Publication |
Language | English |
Published |
2013
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | In the context of worldwide increasing antimicrobial resistance, good antimicrobial prescribing in more needed than ever; unfortunately, information available to clinicians often are insufficient to rely on. Biomarkers might provide help for decision-making and improve antibiotic management. The purpose of this expert panel review was to examine currently available literature on the potential role of biomarkers to improve antimicrobial prescribing, by answering three questions: 1) Which are the biomarkers available for this purpose?; 2) What is their potential role in the initiation of antibiotic therapy?; and 3) What is their role in the decision to stop antibiotic therapy? To answer these questions, studies reviewed were limited to recent clinical studies (<15 years), involving a substantial number of patients (>50) and restricted to controlled trials and meta-analyses for answering questions 2 and 3. With regard to the first question concerning routinely available biomarkers, which might be useful for antibiotic management of acute infections, these are currently limited to C-reactive protein (CRP) and procalcitonin (PCT). Other promising biomarkers that may prove useful in the near future but need to undergo more extensive clinical testing include sTREM-1, suPAR, ProADM, and Presepsin. New approaches to biomarkers of infections include point-of-care testing and genomics. |
---|---|
AbstractList | In the context of worldwide increasing antimicrobial resistance, good antimicrobial prescribing in more needed than ever; unfortunately, information available to clinicians often are insufficient to rely on. Biomarkers might provide help for decision-making and improve antibiotic management. The purpose of this expert panel review was to examine currently available literature on the potential role of biomarkers to improve antimicrobial prescribing, by answering three questions: 1) Which are the biomarkers available for this purpose?; 2) What is their potential role in the initiation of antibiotic therapy?; and 3) What is their role in the decision to stop antibiotic therapy? To answer these questions, studies reviewed were limited to recent clinical studies (<15 years), involving a substantial number of patients (>50) and restricted to controlled trials and meta-analyses for answering questions 2 and 3. With regard to the first question concerning routinely available biomarkers, which might be useful for antibiotic management of acute infections, these are currently limited to C-reactive protein (CRP) and procalcitonin (PCT). Other promising biomarkers that may prove useful in the near future but need to undergo more extensive clinical testing include sTREM-1, suPAR, ProADM, and Presepsin. New approaches to biomarkers of infections include point-of-care testing and genomics. |
Author | Dupuy, Anne-Marie Quenot, Jean-Pierre Luyt, Charles-Edouard Gauzit, Rémy Gras-Le Guen, Christele Claessens, Yann-Eric Pugin, Jérôme Stahl, Jean-Paul Brun-Buisson, Christian Chalumeau, Martin Roche, Nicolas Ruiz, Stéphanie Pean, Yves Lasocki, Sigismond Philippart, Francois Bedos, Jean-Pierre Misset, Benoit Charles, Pierre Emmanuel |
Author_xml | – sequence: 1 fullname: Dupuy, Anne-Marie – sequence: 2 fullname: Philippart, Francois – sequence: 3 fullname: Pean, Yves – sequence: 4 fullname: Lasocki, Sigismond – sequence: 5 fullname: Charles, Pierre Emmanuel – sequence: 6 fullname: Chalumeau, Martin – sequence: 7 fullname: Claessens, Yann-Eric – sequence: 8 fullname: Quenot, Jean-Pierre – sequence: 9 fullname: Gras-Le Guen, Christele – sequence: 10 fullname: Ruiz, Stéphanie – sequence: 11 fullname: Luyt, Charles-Edouard – sequence: 12 fullname: Roche, Nicolas – sequence: 13 fullname: Stahl, Jean-Paul – sequence: 14 fullname: Bedos, Jean-Pierre – sequence: 15 fullname: Pugin, Jérôme – sequence: 16 fullname: Gauzit, Rémy – sequence: 17 fullname: Misset, Benoit – sequence: 18 fullname: Brun-Buisson, Christian |
BookMark | eNqFjU0KwkAMRrvQhX9HEHKBgnYh4lYU3Rb3JQ6ZGpxmSmaq9jDe1Sm4cOcmCXnfx5tmI_FCk-xdekfgLVzZN6h30gAsEG8EDQrW1JDEgaNETpnIZoCKbQ-79AR6taQRWhRyoPRgeiZwhhxMp5rKrgd8IDu8JtGPxXoF41jYoIMu0KBF08XhsGQiewnzbGzRBVp89yxbHg-X_Sm36CuslUN1LIvVelOsN9s0__EPNgxRQg |
ContentType | Publication |
DBID | FBQ |
DatabaseName | AGRIS |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | no_fulltext_linktorsrc |
ExternalDocumentID | FR2016216816 |
GroupedDBID | FBQ |
ID | FETCH-fao_agris_FR20162168162 |
IngestDate | Tue Nov 07 23:21:34 EST 2023 |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-fao_agris_FR20162168162 |
Notes | 10.1186/2110-5820-3-22 http://prodinra.inra.fr/record/223777 http://prodinra.inra.fr/ft/6FDFB16D-EC37-4ED6-8762-6F7638488B60 |
ParticipantIDs | fao_agris_FR2016216816 |
PublicationCentury | 2000 |
PublicationDate | 2013 |
PublicationDateYYYYMMDD | 2013-01-01 |
PublicationDate_xml | – year: 2013 text: 2013 |
PublicationDecade | 2010 |
PublicationTitle | Annals of intensive care 1 (3), 1-8. (2013) |
PublicationYear | 2013 |
Score | 2.8658106 |
Snippet | In the context of worldwide increasing antimicrobial resistance, good antimicrobial prescribing in more needed than ever; unfortunately, information available... |
SourceID | fao |
SourceType | Publisher |
SubjectTerms | biomarker biomarqueur C-reactive protein emergency medicine infection proADM procalcitonin resepsin Santé publique et épidémiologie sepsis septicemie sTREM-1 suPAR |
Title | Role of biomarkers in the management of antibiotic therapy : an expert panel review : I - currently available biomarkers for clinical use in acute infections |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1NS8NAEIYXqxc9KVr8qszBW0kxaZImHv0orVjBWqGeyma7KYGaFPsB9b_4X53ZNMmKFdRLSHYhS_YJy2TyvrOMnVueEzYE94163bUN25eWEQgHv1Icq8H9ofBEg7zDnQe39Wzf9Z1-sb2VcpfMgpp4X-sr-Q9VbEOu5JL9A9n8ptiA58gXj0gYj79i3F1JA8lDTzKbt2kmW3zNVS3qR39MzpCEarOmfqulygTwVYH_WRWXBDnObCzU1a4aVZGWbhovq3zBo7HyWGkjkT4x91XOp6r4CBckO8gEXqtE4LdSzVEum1e6M5OiXEr4Em7T8Gp0jRGDngO-mU_my1SAGUujQx_4-v-MaDLhqfdIbRSSRFNtyVfr6suiEEvec3wl0-26n6JRNEVeQz37QTtR5NmPr2Wym13sdi3T9Uy3xEoNj5a75tUjxgwh12OG3i7b0VKie2xDxvvsg4hBEkIxjxDFgFCgIEb9BTFYEYNLbISUFyhekPLCjjYYkNOCnJY-CtKCjBYgLRpW0YKC1gGrNG971y0DH2XAR7j8D_TntcpsM05ieciAB1JK7pvOMAxs_8IPTIkBMQbpUkhbhOKIldff4_injhO2XUz8KdsK8V2RFYzEZsGZmuFPK65Cxg |
link.rule.ids | 786 |
linkProvider | FAO Food and Agriculture Organization of the United Nations |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+biomarkers+in+the+management+of+antibiotic+therapy+%3A+an+expert+panel+review+%3A+I+-+currently+available+biomarkers+for+clinical+use+in+acute+infections&rft.jtitle=Annals+of+intensive+care+1+%283%29%2C+1-8.+%282013%29&rft.au=Dupuy%2C+Anne-Marie&rft.au=Philippart%2C+Francois&rft.au=Pean%2C+Yves&rft.au=Lasocki%2C+Sigismond&rft.date=2013-01-01&rft.externalDocID=FR2016216816 |